Slashdot Mirror


Killing Cancer With a Virus

just___giver writes "The U.S. National Cancer Institute has just decided to fund multiple human clinical studies to test the reovirus. This naturally occuring virus has a remarkable ability to infect and kill cancer cells, without affecting normal, healthy cells. Here is a before and after picture of a terminal patient with an actively growing neck tumour that had failed to respond to conventional treatments. This tumour was eliminated with only a single injection of the Reovirus. Researchers at Oncolytics Biotech have shown that the Reovirus can kill many types of cancer, including breast, prostate, pancreatic and brain tumours. Human clinical trial results indicate that there are no safety concerns and that the reovirus shrinks and even eliminates tumours injected with this virus. Numerous other third party studies show that the reovirus should be an important discovery in the treatment of 2/3 of all human cancers."

14 of 662 comments (clear)

  1. Poor FARK.com by Anonymous Coward · · Score: 5, Funny

    They aren't going to be able to use headlines like this anymore on their stories:

    Scientific study concludes that eating a lot of fast food and sitting in front of the TV makes you fat. Still no cure for cancer.

  2. Re:Okay, lets try it then... by RLW · · Score: 5, Insightful

    Hope *is* better than nothing. New treatments are tried on terminal patients all the time: just like the person in the before and after links. However, non-terminal patients are not given experimental treatments until the studies are completed based on the effects experienced from the first group: the group everyone hopes they're never in. Once the medical community is convinced that this really works and once they have a handle on the side effects then the treatment will move outward from the most critically ill to other may benefit from it.

  3. Ever happen naturally? by mariox19 · · Score: 5, Interesting

    Reading the article (which by the way puts one in the top 1% of /. readers), it seems this reovirus is quite common, and that non-cancerous cells kill it off quite readily. I wonder though if this reovirus has ever "wandered in" on cancer cells in a patient and led to remission in that patient.

    You always here anecdotal stories about some people recovering in cases where others haven't, and it's usually attributed to God, positive thinking, a close family, and so forth.

    Maybe it's been these little buggers all along.

    --

    quiquid id est, timeo puellas et oscula dantes.

  4. old soviet PHAGE technique by peter303 · · Score: 5, Interesting

    Using viruses to attack diseases is a technique from the early 20th century. It was widely used in Russia, but fell out of favor when anitbiotics were discovered. It appears to be reviving.

  5. Re:good... by Zathrus · · Score: 5, Interesting

    I've seen the effects too -- my father died of cancer, my mother had breast cancer (caught it amazingly early fortunately), I worked on an oncology floor at a local hospital for three years, and one of my coworker's kids has leukemia (in the last stages of treatment, fortunately, and doing well).

    The chemotherapy and radiotherapy is nasty, and this looks a lot better (at least, as long as it doesn't mutate as viruses are wont to do). But very few people actually die from the chemo/radiotherapy, at least not directly. A lot of people don't find out that they have cancer until the cancer is well formed. Once the cancer metastatizes and starts to spread there's very little that modern medicine can do for you (this may change that, as may the nanotech "bullets" I read about earlier today). All chemo and radiation can do at that point is attempt to minimize the suffering -- and I question that they do this for the most part.

    Anyway, it's not the chemo/radiation that gets you. It's the side effects. By and large we use the same chemo drugs that we've used for decades, as well as the same radiotherapy methods. We've refined the dosages, but that's about it. Where the real breakthroughs have been is in the medicines to treat the side effects of the chemo -- nausea, dizziness, low white blood count, and so forth. And we've made strides on drugs to treat the side effects of those drugs. And so forth. Cancers that were fatal (as in 0% survival rate) twenty years ago now have an 80% survivability rate (my coworker's son is one such case). That's pretty amazing.

    Even so, if there's a better solution out there, with fewer side effects, let's go for it. I hope the testing goes well. I'd also like to know what you need to do to be put on the human testing list. My sister's mother-in-law has been given less than 6 months to live, in part due to cancer that has metastatized and is pretty much everywhere now. It's likely that the cancer's done too much damage for her to recover though... and we don't have a magic bullet to cure that issue. Yet.

  6. Re:How do they know? by sosume · · Score: 5, Informative

    When you are trying to fight cancer with an adenovirus, like a particularly nasty common cold, you get a mutated adenovirus that seems to copy itself only in cells that lack a functioning copy of a gene called p53 that repairs damaged or mutated DNA. If the DNA is then too smashed up to be repaired, p53 instructs the cell to self-destruct. Since cancer occurs when DNA becomes so badly battered that it stops regulating cell growth and behavior, it is not surprising p53 has stopped working in more than half of human tumors..

  7. Re:Clarify by JoeLinux · · Score: 5, Interesting

    Worse than that is this:

    ALBUQUERQUE, N.M. (AP) -- A Sandia National Laboratories researcher has discovered a material that could potentially mean a new AIDS treatment. The material, called niobium HPA, can attach itself to the AIDS virus in the bloodstream, preventing it from harming other cells. May Nyman stumbled onto it accidentally while investigating filters for liquid nuclear waste at the Department of Energy's Savannah River Site in South Carolina. The idea of using the discovery for medical purposes is intriguing, said Craig Hill, a chemistry professor at Emory University in Atlanta and an expert in a class of materials called heteropolyanions, or HPAs. "If the thing has a lifetime of hours [in the blood] versus minutes or seconds, then it is very likely to have interesting anti-viral properties," said Hill, who said he would be interested in testing the material at Emory. "There's a reasonable chance that its toxicity may be fairly low."

    So the big bad nuclear power plants so reviled by hippies may cure AIDS. Oh the irony.

  8. Re:Beat me to it. by Rorschach1 · · Score: 5, Funny

    Well, you're halfway there already. Regular slashdot use is shown to completely halt maturity!

  9. Slashdot editors: still asleep at the wheel. by Doktor+Memory · · Score: 5, Informative

    Blatant astroturfing: this article is hyping a completely unproven treatment, and was written by an employee of the company. This is news? Every biotech company has a "promising" anti-cancer treatment in development.

    --

    News for Nerds. Stuff that Matters? Like hell.

  10. Physician perspective by The+Tyro · · Score: 5, Interesting

    it's not necessarily different by country... it even varies by state. My state, for instance, just passed malpractice caps on noneconomic damages... and even despite that, I'm in the process of losing my malpractice insurance (despite having NO claims against me). They are dropping me like a bad habit, and if I want to stayed insured, it's going to cost me double what it was before (that's if I can even get insured).

    Most of these unlabeled uses of drugs/viruses/devices are done under compassionate use protocols of one type or another. There is also "emergency use," which can even be done before clinical trials... try this link for some more info.

    Even so, you should read the fine print. Even for emergency use, you still have to consult your IRB (that's "institutional review board" for you non-medical folks... they can veto what you want to do), and at least one other physician before submitting the paperwork... and who knows how long before your approval comes back? I've not personally submitted one of these (I am not an oncologist), so I won't speculate on the time frame, though I'd hope they would bypass the usual beauracratic delays.

    --
    Even if a man chops off your hand with a sword, you still have two nice, sharp bones to stick in his eyes.
  11. Re:good... by CrackHappy · · Score: 5, Informative

    I had cancer. Thank God they were able to cut it out. I can't stress enough the importance of getting your ass to the doctor if you even suspect something is wrong. All you young men out there, listen up. Testicular cancer is MOST LIKELY to strike between the ages of 25-35. Also note, 98% of ALL masses detected in testicles are cancerous. In other words, when fondling yourself, if you notice anything weird at all, especially anything hard, get yourself checked by your doctor ASAP. Also note Testicular cancer is one of the fastest spreading cancers, but also the easiest to cure, IF it's caught early enough.

    The treatment sucks, but it's better than dying!

    --
    1f u c4n r34d th1s u r34lly n33d t0 g37 l41d Capitalization really works: i helped my uncle jack off a horse
  12. Re:Okay, lets try it then... by Walter+Wart · · Score: 5, Informative
    There are many other concerns among them are:
    1. How much of the experimental agent do you have? These things are often expensive, rare and certainly not covered by insurance
    2. You have to pick your subjects carefully if you want to get useful results. The point of a study is to study.
    3. There are compassionate exemptions. Later posts by "The Tyro" go into these in great detail.
    4. Liability. How do you guard against lawsuits if the treatment has unforseen side effects? Waivers can be fought.
    5. By the time a person is terminal he or she is often not a good candidate for a haircut much less an experimental drug or procedure. Getting back to the limited supplies and "do no harm" principles someone has to decide whether the experimental substance is better given to someone who has a better chance of survival.


    Speaking personally, I just underwent surgery and am awaiting radiation for a tumor. I would have much prefer to have gotten an injection, a severe cold, no tumor, and the continued use of an important body part. But I was not selected for such a study and couldn't have paid for the drug anyway. Such is life. I am just glad that my prognosis is good and hope that the virus will be approved as soon as is scientifically appropriate.
    --
    The man who never alters his opinion is like the stagnant water and breeds Reptiles of the Mind -- William Blake
  13. Re:Then it gets patented. by Zathrus · · Score: 5, Interesting

    What a load of crap.

    Yes, a company could patent the usage of this retrovirus for curing cancer. Sure, the virus has existed for some unknown amount of time, but the usage of it as a method to cure cancer would certainly fulfill the "new" and "non-obvious" requirements for patent law.

    And, hey, maybe they'll make some money on doing so as long as they license it widely at some low cost. After all, they certainly spent some money in finding out that the retrovirus causes the anti-cancer effect, and paid for the trials, and whatnot to go forward. Shouldn't they receive some compensation for doing so?

    And what will happen if they try to charge too much for it? Particularly if the retrovirus can be easily manufactured from existing natural sources?

    They'll discover that countries will nationalize their patent and they'll get bupkis. It's happened before, both in and outside of the US, and it'll happen again. And even for similar causes. Numerous South American and African countries do not recognize the patents on various HIV medications. The drug companies have been told that they can either sell it for a fixed price (or, more likely, be paid a fixed amount by the government regardless of how much is administered) or the government will simply nationalize the patent and the drug companies will get nothing. Generally they go for the settlement.

    Of course, it's not that simple. Every time this occurs it's a disincentive for the drug companies to actually produce miracle cures, or even to produce treatment drugs for maladies. Do you spend $100M on research for degenerative neural disorders like Alzheimer's and MS, knowing that if you succeed you might never see the money back, or do you spend it on a drug to reduce anxiety, depression, or other sociological problems -- which aren't likely to ever be nationalized? And while I agree that drugs are often overpriced, the flip side to that is it's hideously expensive to actually get a new drug approved by the FDA and its counterparts (mostly in Europe). It costs millions of dollars. And most of them fail to get through the process. You can look at streamlining the process, but then you run the risk of having drugs with very bad side effects slipping through.

    Do you want to leave actually finding cures up to purely governmental/good will efforts? Especially when a lot of the best are going to go into private industry because the pay is better?

    Sorry, the real world isn't as simple as your flippant "intellectual property" comment. It's far more complex, and there are no easy solutions.

  14. It's only Phase II, not ready for prime time by nbauman · · Score: 5, Informative
    This work is scientifically very interesting but it's a long way from curing cancer.

    On the Oncolytics web site, they only list Phase I and Phase II trials. That's just to evaluate safety and dosing. In Phase III, they finally get around to testing for effectiveness, and they haven't done that yet.

    I've seen lots of drugs that did this well in Phase II trials but flunked Phase III. I remember seeing Fortune magazine with the headline on the cover, "Cure for Cancer!" 20 years ago. Unfortunately not. (They got over-enthusiastic about cancer vaccines.)

    Phase III is a randomized controlled trial. They randomly assign half the patients to the drug, and half the patients to a placebo. If it really works, you should see the difference. A lot of times it doesn't work and you know the drug is useless. Until the RCT you don't know anything for sure.

    Another distinction you have to make is the end point. It's one thing to shrink a tumor, but the main thing most cancer patients are interested in is whether they're going to die. There are a lot of drugs that shrink tumors, but have no effect on how long they live.

    Here's a discussion, "Levels of Clinical Evidence in the Primary Literature" which describes the different levels of evidence. Or look at BMJ Or if you want to search Google look for "Evidence-based medicine."

    I hope this will encourage investors to throw lots of money at basic research and give us a better understanding of why cells become cancerous. It makes the New England Journal of Medicine more fun to read. Who knows? Maybe they'll come up with something useful some day. But not today.